Traws Pharma, Inc.TRAWNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank12
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P12
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q2 2025-48.00%
Q4 202458.99%
Q2 2024-122.39%
Q4 20231.34%
Q2 2023-15.60%
Q4 20227.83%
Q2 20221.20%
Q4 20210.98%
Q2 202121.23%
Q4 2020-1.62%
Q2 2020-0.39%
Q4 2019-9.19%
Q2 20199.24%
Q4 2018-16.98%
Q2 20181.05%
Q4 201760.23%
Q2 2017-62.75%
Q4 201616.00%
Q2 201633.44%
Q4 201529.55%
Q2 201533.27%
Q4 20149.02%
Q2 20144.17%
Q4 2013-5.41%
Q2 2013-315.30%
Q4 2012213.33%
Q2 20120.00%